nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—CYP3A4—bone cancer	0.506	1	CbGaD
Chenodeoxycholic acid—UGT2B7—Epirubicin—bone cancer	0.217	0.948	CbGbCtD
Chenodeoxycholic acid—NR1H4—skull—bone cancer	0.0146	0.205	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—bone cancer	0.0118	0.0517	CbGbCtD
Chenodeoxycholic acid—CYP27A1—vertebral column—bone cancer	0.0107	0.15	CbGeAlD
Chenodeoxycholic acid—CYP27A1—leg—bone cancer	0.0103	0.144	CbGeAlD
Chenodeoxycholic acid—CYP27A1—forelimb—bone cancer	0.0102	0.143	CbGeAlD
Chenodeoxycholic acid—CYP27A1—hindlimb—bone cancer	0.00919	0.129	CbGeAlD
Chenodeoxycholic acid—CYP27A1—appendage—bone cancer	0.00788	0.111	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00771	0.125	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0053	0.0856	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00353	0.057	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP4V2—bone cancer	0.00332	0.0536	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00309	0.05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—connective tissue—bone cancer	0.00309	0.0434	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00304	0.0492	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00283	0.0458	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—connective tissue—bone cancer	0.00225	0.0316	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0022	0.0356	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Estrogen metabolism—CYP3A4—bone cancer	0.00184	0.0298	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00178	0.0287	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Tamoxifen metabolism—CYP3A4—bone cancer	0.00163	0.0263	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—tendon—bone cancer	0.00155	0.0217	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00154	0.025	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Orphan transporters—TUBB4B—bone cancer	0.00153	0.0247	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00152	0.0246	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP4V2—bone cancer	0.00151	0.0244	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—spinal cord—bone cancer	0.00149	0.0209	CbGeAlD
Chenodeoxycholic acid—NR1H4—Orphan transporters—TUBB2A—bone cancer	0.00132	0.0213	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00125	0.0202	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00113	0.0182	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ZNF77—bone cancer	0.00112	0.0181	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000915	0.0148	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000806	0.013	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000758	0.0123	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP3A4—bone cancer	0.000665	0.0107	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000656	0.0106	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTP1—bone cancer	0.000569	0.00919	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTP1—bone cancer	0.000561	0.00907	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—ZNF77—bone cancer	0.00054	0.00874	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP3A4—bone cancer	0.000486	0.00786	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTP1—bone cancer	0.000443	0.00716	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000436	0.00704	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTP1—bone cancer	0.000416	0.00672	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NDUFA12—bone cancer	0.000399	0.00644	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NR1I2—bone cancer	0.00038	0.00614	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000373	0.00602	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000347	0.00561	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NT5C3A—bone cancer	0.00033	0.00534	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000322	0.0052	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000303	0.0049	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000299	0.00483	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000295	0.00477	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000295	0.00477	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NDUFA12—bone cancer	0.000291	0.00471	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—FUS—bone cancer	0.000264	0.00427	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000259	0.00419	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000255	0.00413	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NT5C3A—bone cancer	0.000241	0.0039	CbGpPWpGaD
Chenodeoxycholic acid—Jaundice—Epirubicin—bone cancer	0.00019	0.00143	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Epirubicin—bone cancer	0.000189	0.00143	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Epirubicin—bone cancer	0.000189	0.00143	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Doxorubicin—bone cancer	0.000189	0.00143	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000188	0.00142	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Methotrexate—bone cancer	0.000188	0.00142	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Methotrexate—bone cancer	0.000187	0.00141	CcSEcCtD
Chenodeoxycholic acid—Sweating—Epirubicin—bone cancer	0.000187	0.00141	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Doxorubicin—bone cancer	0.000187	0.00141	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Epirubicin—bone cancer	0.000186	0.0014	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Methotrexate—bone cancer	0.000185	0.0014	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Methotrexate—bone cancer	0.000184	0.00139	CcSEcCtD
Chenodeoxycholic acid—Photosensitivity reaction—Doxorubicin—bone cancer	0.000184	0.00139	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Epirubicin—bone cancer	0.000184	0.00139	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Doxorubicin—bone cancer	0.000184	0.00139	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Epirubicin—bone cancer	0.000184	0.00139	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Methotrexate—bone cancer	0.000183	0.00138	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—NR1I2—bone cancer	0.000183	0.00296	CbGpPWpGaD
Chenodeoxycholic acid—Weight decreased—Doxorubicin—bone cancer	0.000183	0.00138	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Epirubicin—bone cancer	0.000183	0.00138	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—NDUFA12—bone cancer	0.000182	0.00293	CbGpPWpGaD
Chenodeoxycholic acid—Pneumonia—Doxorubicin—bone cancer	0.000181	0.00137	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Doxorubicin—bone cancer	0.00018	0.00136	CcSEcCtD
Chenodeoxycholic acid—Infestation—Doxorubicin—bone cancer	0.00018	0.00136	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Methotrexate—bone cancer	0.00018	0.00136	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Cisplatin—bone cancer	0.000178	0.00134	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Doxorubicin—bone cancer	0.000177	0.00134	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Epirubicin—bone cancer	0.000176	0.00133	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Doxorubicin—bone cancer	0.000176	0.00132	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Epirubicin—bone cancer	0.000175	0.00132	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Doxorubicin—bone cancer	0.000175	0.00132	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Doxorubicin—bone cancer	0.000175	0.00132	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Epirubicin—bone cancer	0.000175	0.00132	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Methotrexate—bone cancer	0.000174	0.00132	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Methotrexate—bone cancer	0.000174	0.00131	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Cisplatin—bone cancer	0.000173	0.00131	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Epirubicin—bone cancer	0.000173	0.00131	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Methotrexate—bone cancer	0.000173	0.00131	CcSEcCtD
Chenodeoxycholic acid—Sweating—Doxorubicin—bone cancer	0.000173	0.0013	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Epirubicin—bone cancer	0.000173	0.0013	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Epirubicin—bone cancer	0.000172	0.0013	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Doxorubicin—bone cancer	0.000172	0.0013	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Epirubicin—bone cancer	0.000172	0.0013	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Epirubicin—bone cancer	0.000171	0.00129	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Doxorubicin—bone cancer	0.00017	0.00129	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Doxorubicin—bone cancer	0.00017	0.00128	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Methotrexate—bone cancer	0.000169	0.00128	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—bone cancer	0.000169	0.00128	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Methotrexate—bone cancer	0.000169	0.00127	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Epirubicin—bone cancer	0.000168	0.00127	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Methotrexate—bone cancer	0.000168	0.00127	CcSEcCtD
Chenodeoxycholic acid—Chills—Methotrexate—bone cancer	0.000167	0.00126	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Cisplatin—bone cancer	0.000165	0.00125	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Methotrexate—bone cancer	0.000165	0.00125	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Epirubicin—bone cancer	0.000163	0.00123	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Epirubicin—bone cancer	0.000163	0.00123	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Methotrexate—bone cancer	0.000163	0.00123	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—bone cancer	0.000162	0.00123	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Epirubicin—bone cancer	0.000162	0.00122	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—bone cancer	0.000162	0.00122	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—bone cancer	0.000162	0.00122	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—bone cancer	0.00016	0.00121	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—bone cancer	0.00016	0.0012	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—bone cancer	0.000159	0.0012	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—bone cancer	0.000159	0.0012	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Epirubicin—bone cancer	0.000158	0.0012	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—bone cancer	0.000158	0.0012	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Epirubicin—bone cancer	0.000158	0.00119	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Epirubicin—bone cancer	0.000157	0.00119	CcSEcCtD
Chenodeoxycholic acid—Back pain—Methotrexate—bone cancer	0.000157	0.00119	CcSEcCtD
Chenodeoxycholic acid—Chills—Epirubicin—bone cancer	0.000157	0.00118	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Epirubicin—bone cancer	0.000156	0.00118	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—bone cancer	0.000156	0.00118	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Epirubicin—bone cancer	0.000154	0.00117	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Cisplatin—bone cancer	0.000154	0.00116	CcSEcCtD
Chenodeoxycholic acid—Rash—Cisplatin—bone cancer	0.000152	0.00115	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Cisplatin—bone cancer	0.000152	0.00115	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Epirubicin—bone cancer	0.000152	0.00115	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—bone cancer	0.000151	0.00114	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Methotrexate—bone cancer	0.000151	0.00114	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—bone cancer	0.000151	0.00114	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—NT5C3A—bone cancer	0.00015	0.00243	CbGpPWpGaD
Chenodeoxycholic acid—Anaemia—Methotrexate—bone cancer	0.00015	0.00113	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—bone cancer	0.00015	0.00113	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Epirubicin—bone cancer	0.00015	0.00113	CcSEcCtD
Chenodeoxycholic acid—Tension—Epirubicin—bone cancer	0.000149	0.00113	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Epirubicin—bone cancer	0.000148	0.00111	CcSEcCtD
Chenodeoxycholic acid—Back pain—Epirubicin—bone cancer	0.000147	0.00111	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—bone cancer	0.000147	0.00111	CcSEcCtD
Chenodeoxycholic acid—Malaise—Methotrexate—bone cancer	0.000147	0.00111	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Epirubicin—bone cancer	0.000146	0.0011	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—bone cancer	0.000146	0.0011	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Methotrexate—bone cancer	0.000146	0.0011	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—bone cancer	0.000146	0.0011	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Methotrexate—bone cancer	0.000145	0.0011	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—bone cancer	0.000145	0.00109	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ENO2—bone cancer	0.000145	0.00234	CbGpPWpGaD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—bone cancer	0.000144	0.00109	CcSEcCtD
Chenodeoxycholic acid—Nausea—Cisplatin—bone cancer	0.000144	0.00108	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Doxorubicin—bone cancer	0.000143	0.00108	CcSEcCtD
Chenodeoxycholic acid—Cough—Methotrexate—bone cancer	0.000142	0.00107	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Epirubicin—bone cancer	0.000141	0.00107	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Methotrexate—bone cancer	0.000141	0.00106	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—bone cancer	0.000141	0.00106	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Epirubicin—bone cancer	0.000141	0.00106	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Doxorubicin—bone cancer	0.000139	0.00105	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Methotrexate—bone cancer	0.000138	0.00104	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Methotrexate—bone cancer	0.000138	0.00104	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Methotrexate—bone cancer	0.000138	0.00104	CcSEcCtD
Chenodeoxycholic acid—Tension—Doxorubicin—bone cancer	0.000138	0.00104	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000137	0.00104	CcSEcCtD
Chenodeoxycholic acid—Malaise—Epirubicin—bone cancer	0.000137	0.00104	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Methotrexate—bone cancer	0.000137	0.00103	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Doxorubicin—bone cancer	0.000137	0.00103	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Epirubicin—bone cancer	0.000137	0.00103	CcSEcCtD
Chenodeoxycholic acid—Syncope—Epirubicin—bone cancer	0.000136	0.00103	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Epirubicin—bone cancer	0.000136	0.00103	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—bone cancer	0.000136	0.00103	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—bone cancer	0.000135	0.00102	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—EIF2S1—bone cancer	0.000135	0.00218	CbGpPWpGaD
Chenodeoxycholic acid—Palpitations—Epirubicin—bone cancer	0.000134	0.00101	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—DHFR—bone cancer	0.000134	0.00217	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Methotrexate—bone cancer	0.000134	0.00101	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Epirubicin—bone cancer	0.000134	0.00101	CcSEcCtD
Chenodeoxycholic acid—Cough—Epirubicin—bone cancer	0.000133	0.001	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Epirubicin—bone cancer	0.000132	0.000995	CcSEcCtD
Chenodeoxycholic acid—Infection—Methotrexate—bone cancer	0.000132	0.000995	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Epirubicin—bone cancer	0.000131	0.000991	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—bone cancer	0.000131	0.000985	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Methotrexate—bone cancer	0.00013	0.000982	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—bone cancer	0.00013	0.000982	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Methotrexate—bone cancer	0.00013	0.00098	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Epirubicin—bone cancer	0.000129	0.000977	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Epirubicin—bone cancer	0.000129	0.000977	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Epirubicin—bone cancer	0.000129	0.000977	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Methotrexate—bone cancer	0.000129	0.000972	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000129	0.000971	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Methotrexate—bone cancer	0.000128	0.000968	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Epirubicin—bone cancer	0.000128	0.000966	CcSEcCtD
Chenodeoxycholic acid—Malaise—Doxorubicin—bone cancer	0.000127	0.000958	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Epirubicin—bone cancer	0.000127	0.000956	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Doxorubicin—bone cancer	0.000126	0.000954	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Methotrexate—bone cancer	0.000126	0.000954	CcSEcCtD
Chenodeoxycholic acid—Syncope—Doxorubicin—bone cancer	0.000126	0.000952	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—bone cancer	0.000126	0.000951	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GNA11—bone cancer	0.000125	0.00203	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Epirubicin—bone cancer	0.000125	0.000945	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Doxorubicin—bone cancer	0.000124	0.000939	CcSEcCtD
Chenodeoxycholic acid—Oedema—Epirubicin—bone cancer	0.000124	0.000937	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Methotrexate—bone cancer	0.000124	0.000935	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—bone cancer	0.000124	0.000933	CcSEcCtD
Chenodeoxycholic acid—Infection—Epirubicin—bone cancer	0.000123	0.000931	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—bone cancer	0.000123	0.000927	CcSEcCtD
Chenodeoxycholic acid—Shock—Epirubicin—bone cancer	0.000122	0.000922	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Doxorubicin—bone cancer	0.000122	0.00092	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Epirubicin—bone cancer	0.000122	0.000919	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Epirubicin—bone cancer	0.000122	0.000917	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Doxorubicin—bone cancer	0.000121	0.000917	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Epirubicin—bone cancer	0.000121	0.000914	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000121	0.000912	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Epirubicin—bone cancer	0.000121	0.00091	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Epirubicin—bone cancer	0.00012	0.000906	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Methotrexate—bone cancer	0.00012	0.000905	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Doxorubicin—bone cancer	0.00012	0.000904	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—bone cancer	0.00012	0.000904	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—bone cancer	0.00012	0.000904	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Methotrexate—bone cancer	0.000119	0.000899	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000119	0.000898	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Doxorubicin—bone cancer	0.000118	0.000893	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Epirubicin—bone cancer	0.000118	0.000893	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Methotrexate—bone cancer	0.000118	0.000892	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Methotrexate—bone cancer	0.000118	0.00089	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—EZH2—bone cancer	0.000117	0.0019	CbGpPWpGaD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—bone cancer	0.000117	0.000884	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Methotrexate—bone cancer	0.000117	0.000881	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Epirubicin—bone cancer	0.000116	0.000875	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Doxorubicin—bone cancer	0.000116	0.000874	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Methotrexate—bone cancer	0.000115	0.00087	CcSEcCtD
Chenodeoxycholic acid—Oedema—Doxorubicin—bone cancer	0.000115	0.000867	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Methotrexate—bone cancer	0.000114	0.000864	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Methotrexate—bone cancer	0.000114	0.000863	CcSEcCtD
Chenodeoxycholic acid—Infection—Doxorubicin—bone cancer	0.000114	0.000861	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP3A4—bone cancer	0.000114	0.00184	CbGpPWpGaD
Chenodeoxycholic acid—Pain—Methotrexate—bone cancer	0.000113	0.000856	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000113	0.00183	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000113	0.000854	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—bone cancer	0.000113	0.000853	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—bone cancer	0.000113	0.00085	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—bone cancer	0.000112	0.000849	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Epirubicin—bone cancer	0.000112	0.000847	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—bone cancer	0.000112	0.000846	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—bone cancer	0.000112	0.000842	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Epirubicin—bone cancer	0.000111	0.000841	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—bone cancer	0.000111	0.000838	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Epirubicin—bone cancer	0.000111	0.000835	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Epirubicin—bone cancer	0.00011	0.000833	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Doxorubicin—bone cancer	0.000109	0.000826	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Methotrexate—bone cancer	0.000109	0.000825	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Epirubicin—bone cancer	0.000109	0.000825	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Methotrexate—bone cancer	0.000108	0.000819	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Epirubicin—bone cancer	0.000108	0.000814	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Doxorubicin—bone cancer	0.000107	0.00081	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Epirubicin—bone cancer	0.000107	0.000809	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Epirubicin—bone cancer	0.000107	0.000808	CcSEcCtD
Chenodeoxycholic acid—Constipation—Epirubicin—bone cancer	0.000106	0.000801	CcSEcCtD
Chenodeoxycholic acid—Pain—Epirubicin—bone cancer	0.000106	0.000801	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ENO2—bone cancer	0.000106	0.00171	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Methotrexate—bone cancer	0.000105	0.000795	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Methotrexate—bone cancer	0.000105	0.000791	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Methotrexate—bone cancer	0.000105	0.000791	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000105	0.00079	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Doxorubicin—bone cancer	0.000104	0.000784	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—bone cancer	0.000103	0.000778	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—bone cancer	0.000102	0.000773	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Epirubicin—bone cancer	0.000102	0.000772	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Doxorubicin—bone cancer	0.000102	0.000771	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Epirubicin—bone cancer	0.000101	0.000766	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—bone cancer	0.000101	0.000763	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—bone cancer	9.98e-05	0.000754	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—bone cancer	9.91e-05	0.000748	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—bone cancer	9.9e-05	0.000747	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Epirubicin—bone cancer	9.86e-05	0.000744	CcSEcCtD
Chenodeoxycholic acid—Pain—Doxorubicin—bone cancer	9.82e-05	0.000741	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—bone cancer	9.82e-05	0.000741	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Epirubicin—bone cancer	9.81e-05	0.000741	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Epirubicin—bone cancer	9.81e-05	0.000741	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—DHFR—bone cancer	9.81e-05	0.00159	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Methotrexate—bone cancer	9.77e-05	0.000738	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTP1—bone cancer	9.73e-05	0.00157	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Methotrexate—bone cancer	9.52e-05	0.000718	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—bone cancer	9.46e-05	0.000714	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—bone cancer	9.39e-05	0.000709	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Methotrexate—bone cancer	9.38e-05	0.000708	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	9.18e-05	0.00148	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GNA11—bone cancer	9.17e-05	0.00148	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Epirubicin—bone cancer	9.14e-05	0.00069	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Doxorubicin—bone cancer	9.12e-05	0.000689	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—bone cancer	9.08e-05	0.000685	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—bone cancer	9.08e-05	0.000685	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Methotrexate—bone cancer	9.07e-05	0.000685	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Epirubicin—bone cancer	8.9e-05	0.000672	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Epirubicin—bone cancer	8.78e-05	0.000663	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Methotrexate—bone cancer	8.77e-05	0.000662	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Epirubicin—bone cancer	8.49e-05	0.000641	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—bone cancer	8.46e-05	0.000639	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Methotrexate—bone cancer	8.43e-05	0.000636	CcSEcCtD
Chenodeoxycholic acid—Rash—Methotrexate—bone cancer	8.36e-05	0.000631	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Methotrexate—bone cancer	8.35e-05	0.000631	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP3A4—bone cancer	8.31e-05	0.00134	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Methotrexate—bone cancer	8.31e-05	0.000627	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.27e-05	0.00134	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Doxorubicin—bone cancer	8.24e-05	0.000622	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Epirubicin—bone cancer	8.21e-05	0.000619	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Doxorubicin—bone cancer	8.12e-05	0.000613	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Epirubicin—bone cancer	7.89e-05	0.000596	CcSEcCtD
Chenodeoxycholic acid—Nausea—Methotrexate—bone cancer	7.88e-05	0.000595	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—bone cancer	7.86e-05	0.000593	CcSEcCtD
Chenodeoxycholic acid—Rash—Epirubicin—bone cancer	7.83e-05	0.000591	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Epirubicin—bone cancer	7.82e-05	0.00059	CcSEcCtD
Chenodeoxycholic acid—Headache—Epirubicin—bone cancer	7.78e-05	0.000587	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Doxorubicin—bone cancer	7.59e-05	0.000573	CcSEcCtD
Chenodeoxycholic acid—Nausea—Epirubicin—bone cancer	7.37e-05	0.000556	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Doxorubicin—bone cancer	7.3e-05	0.000551	CcSEcCtD
Chenodeoxycholic acid—Rash—Doxorubicin—bone cancer	7.24e-05	0.000547	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—bone cancer	7.23e-05	0.000546	CcSEcCtD
Chenodeoxycholic acid—Headache—Doxorubicin—bone cancer	7.19e-05	0.000543	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTP1—bone cancer	7.11e-05	0.00115	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Doxorubicin—bone cancer	6.82e-05	0.000515	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—ENO2—bone cancer	6.59e-05	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—DHFR—bone cancer	6.11e-05	0.000988	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.95e-05	0.000962	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.87e-05	0.000948	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GNA11—bone cancer	5.71e-05	0.000924	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP3A4—bone cancer	5.18e-05	0.000837	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—bone cancer	5.04e-05	0.000815	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTP1—bone cancer	4.43e-05	0.000716	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NDUFA12—bone cancer	4.17e-05	0.000674	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—bone cancer	3.68e-05	0.000595	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NT5C3A—bone cancer	3.45e-05	0.000558	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—bone cancer	2.29e-05	0.000371	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ENO2—bone cancer	1.51e-05	0.000245	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—DHFR—bone cancer	1.4e-05	0.000227	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GNA11—bone cancer	1.31e-05	0.000212	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTP1—bone cancer	1.02e-05	0.000164	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—bone cancer	5.27e-06	8.52e-05	CbGpPWpGaD
